Correlation Between Neurobo Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Neurobo Pharmaceuticals and Virax Biolabs
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neurobo and Virax is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.52 times more return on investment than Virax Biolabs. However, Neurobo Pharmaceuticals is 1.94 times less risky than Virax Biolabs. It trades about -0.1 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.13 per unit of risk. If you would invest 340.00 in Neurobo Pharmaceuticals on August 23, 2024 and sell it today you would lose (105.00) from holding Neurobo Pharmaceuticals or give up 30.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| Virax Biolabs Group |
Neurobo Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Neurobo Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.The idea behind Neurobo Pharmaceuticals and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Virax Biolabs vs. ZyVersa Therapeutics | Virax Biolabs vs. Sonnet Biotherapeutics Holdings | Virax Biolabs vs. Zura Bio Limited | Virax Biolabs vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |